Lymphatic filariasis elimination and schistosomiasis control in combination with onchocerciasis control in Nigeria.

This paper describes a pilot initiative to incorporate lymphatic filariasis (LF) elimination and urinary schistosomiasis (SH) control into a mature onchocerciasis control program based on community-directed ivermectin treatment in central Nigeria. In the same districts having onchocerciasis we found LF (as determined by blood antigen testing in adult males) in 90% of 149 villages with a mean prevalence of 22.4% (range 0-67%). Similarly, SH, as determined by dipstick reagent testing for blood in urine from school children, was found in 91% of 176 villages with a mean orevalence in school age children of 24.4% (range 0-87%). Health education and treatment interventions for SH resulted in 52,480 cumulative praziquantel treatments, and 159,555 combined onchocerciasis and LF treatments (with ivermectin and albendazole) as of the end of 2000. Treatments for onchocerciasis and LF were separated by at least 1 week from treatments for SH. There was no negative impact on the coverage of the onchocerciasis program by the addition of LF and SH activities.

[1]  F. Richards,et al.  Control of onchocerciasis today: status and challenges. , 2001, Trends in parasitology.

[2]  C. J. Thomas,et al.  Mapping and estimating the population at risk from lymphatic filariasis in Africa. , 2000, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[3]  S. Adjei,et al.  Alternatives to bodyweight for estimating the dose of praziquantel needed to treat schistosomiasis. , 1999, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[4]  E. Ottesen,et al.  The role of albendazole in programmes to eliminate lymphatic filariasis. , 1999, Parasitology today.

[5]  G. Webbe.  Community-Wide Treatment of Schistosomiasis with Praziquantel , 1999, Tropical doctor.

[6]  J. Jiya.  Problems and perspective in programme management: the case of the National Onchocerciasis Control Programme in Nigeria. , 1998, Annals of tropical medicine and parasitology.

[7]  A. Omojola,et al.  Human onchocerciasis: current assessment of the disease burden in Nigeria by rapid epidemiological mapping. , 1998, Annals of tropical medicine and parasitology.

[8]  G. Weil,et al.  The ICT Filariasis Test: A rapid-format antigen test for diagnosis of bancroftian filariasis. , 1997, Parasitology today.

[9]  A. Hightower,et al.  Randomised placebo-controlled comparison of ivermectin and albendazole alone and in combination for Wuchereria bancrofti microfilaraemia in Haitian children , 1997, The Lancet.

[10]  B. Duke,et al.  Strategies and tools for the control/elimination of lymphatic filariasis. , 1997, Bulletin of the World Health Organization.

[11]  F. Richards,et al.  Community-based ivermectin distributors: onchocerciasis control at the village level in Plateau State, Nigeria. , 1996, Acta tropica.

[12]  R. Sturrock.  The control of schistosomiasis. Second report of the WHO Expert Committee. , 1993, World Health Organization technical report series.

[13]  Amuta Eu,et al.  Observations on mansonellosis among the Ibos of Abia and Imo States, Nigeria. , 1992 .

[14]  D. Hopkins.  Homing in on helminths. , 1992, The American journal of tropical medicine and hygiene.

[15]  J. K. Udonsi.  Filariasis in the Igwun River Basin, Nigeria: an epidemiological and clinical study with a note on the vectors. , 1988, Annals of tropical medicine and parasitology.

[16]  W. Kershaw,et al.  Some observations on the distribution of filariasis and onchocerciasis in Nigeria and the British Cameroons. , 1953 .

[17]  B. J. Couktney.  The Association of Certain Common Complaints as seen in Native Hospital Patients with the Presence of Microfilariae in the Blood. , 2022 .